Systemic Mastocytosis
RareBlood Disorders
Systemic Mastocytosis is treated with 2 medications in our database, including Gastrocrom, Cromolyn Sodium Oral Solution (Concentrate). 2 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Viatris Specialty LLC, Mylan. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Systemic Mastocytosis treatment below.
What help exists for Systemic Mastocytosis
15
drugs indexed
7
with copay cards
8
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Systemic Mastocytosis
15 totalIMKELDI
imatinib oral Β· Sumitomo Pharma
ππRanitidine Hydrochloride
Ranitidine Hydrochloride Β· GlaxoSmithKline
CIMETIDINE HYDROCHLORIDE
CIMETIDINE HYDROCHLORIDE Β· GlaxoSmithKline
RYDAPT
RYDAPT
Imatinib
imatinib mesylate
ππAyvakit
avapritinib Β· Blueprint
ππOMEPRAZOLE
Omeprazole
ππRANITIDINE
Ranitidine Β· GlaxoSmithKline
Omeprazole DR
Omeprazole
CIMETIDINE
Cimetidine Β· GlaxoSmithKline
Cromolyn Sodium Oral Solution (Concentrate)
Cromolyn Sodium Β· Mylan
Imatinib mesylate 400 mg
imatinib mesylate
ππGastrocrom
cromolyn sodium Β· Viatris Specialty LLC
πGleevec
imatinib mesylate
ππIMATINIB MESYLATE
imatinib mesylate
ππ
π = copay card Β· π = patient assistance program
Prior authorization patterns for Systemic Mastocytosis drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
Showing 10 of 22 PA rules for Systemic Mastocytosis drugs. View individual drug pages for complete PA detail.
Systemic Mastocytosis is a rare disease β more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare β